肝细胞癌经导管动脉化疗栓塞术中灌注血管造影变化可预测短期结局
这项前瞻性研究纳入172例肝细胞癌患者(187个病灶),在TACE术前术后行二维灌注血管造影,评估灌注参数变化与短期肿瘤反应的关系。所有灌注参数在TACE前后均有显著差异(p<0.001),AUC的围手术期变化与短期肿瘤反应显著相关(OR 1.535,95%CI 1.314-1.793,p<0.001)。二维灌注血管造影可客观量化灌注减少并预测TACE短期肿瘤反应。
要点
- TACE前后二维灌注血管造影各参数均显著变化(p<0.001)。
- AUC变化与短期肿瘤反应显著相关(OR 1.535,95%CI 1.314-1.793)。
- 二维灌注血管造影可客观量化TACE所致灌注减少。
核心结论
- 二维灌注血管造影可客观量化TACE所致灌注减少,并预测肝细胞癌患者对TACE的短期肿瘤反应。
研究设计与样本
- 前瞻性研究,纳入2015年11月至2017年11月间接受TACE的172例肝细胞癌患者(144男、28女,平均年龄65.4±10.2岁),共187个符合标准的病灶(所有离散病灶≥1.5 cm);TACE前后行二维灌注血管造影,并回顾术前术后CT;以改良实体瘤疗效评价标准评估肿瘤反应;采用Wilcoxon符号秩检验比较灌注参数,多因素logistic回归分析参数变化与客观肿瘤反应的相关性。
诊断标准与关键数值
- 二维灌注血管造影参数包括到达时间、达峰时间、流入速率、宽度、AUC和平均通过时间;所有参数TACE后较术前显著不同(p<0.001);AUC围手术期变化与短期肿瘤反应显著相关(OR 1.535,95%CI 1.314-1.793,p<0.001)。
临床应用与阅片要点
- 阅片时可关注TACE前后二维灌注血管造影的AUC变化,原文显示其与短期肿瘤反应显著相关(OR 1.535,95%CI 1.314-1.793)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study is to quantitatively assess perfusion reductions occurring in hepatocellular carcinoma (HCC) during transcatheter arterial chemoembolization (TACE) using 2D perfusion angiography and to evaluate the relationships between various 2D perfusion angiography parameter changes and short-term tumor response. SUBJECTS AND METHODS. This prospective study included 172 patients (144 men and 28 women; mean [± SD] age, 65.4 ± 10.2 years) who underwent TACE for HCC between November 2015 and November 2017. Two-dimensional perfusion angiography was performed before and after TACE. Pre- and postprocedural CT images were also reviewed. Index lesions were defined as all discrete lesions 1.5 cm or larger. The tumor response was assessed using the modified Response Evaluation Criteria in Solid Tumors. Periprocedural 2D perfusion angiography parameters, including the arrival time, time to peak, wash-in rate, width, AUC, and mean transit time, were compared using the Wilcoxon signed rank test. Correlations between 2D perfusion angiography parameter changes and objective tumor response were evaluated using multivariate logistic regression analysis. RESULTS. A total of 187 lesions meeting the inclusion criteria were identified in 172 patients. All analyzed 2D perfusion angiography parameters were significantly different after versus before TACE (p < 0.001). A significant relationship between periprocedural change in AUC and short-term tumor response was found (odds ratio, 1.535; 95% CI, 1.314-1.793; p < 0.001). CONCLUSION. Two-dimensional perfusion angiography could objectively quantify perfusion reductions and predict short-term tumor response to TACE in patients with HCC.
引用
- Kim HO, Yim NY, Kim JK, et al. Change in Perfusion Angiography During Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Predicts Short-Term Outcomes. AJR Am J Roentgenol. 2019. PMID: 31039020. doi:10.2214/AJR.18.20499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。